{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:29:21Z","timestamp":1790695761153,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1414,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.jacc.2009.05.061","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T10:46:05Z","timestamp":1253702765000},"page":"1238-1245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease"],"prefix":"10.1016","volume":"54","author":[{"given":"Jakub J.","family":"Regieli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"Doevendans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeilko H.","family":"Zwinderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederick E.","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2009.05.061_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0002-9149(99)00826-7","article-title":"Raising low levels of high-density lipoprotein cholesterol is an important target of therapy (abstr)","volume":"85","author":"Boden","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.05.061_bib2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.061_bib3","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.97.15.1446","article-title":"Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial","volume":"97","author":"Sacks","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.061_bib4","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.102.16.1893","article-title":"Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.061_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0005-2760(90)90314-N","article-title":"High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein","volume":"1044","author":"Parthasarathy","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2009.05.061_bib6","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1172\/JCI114271","article-title":"Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man","volume":"84","author":"Yla-Herttuala","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2009.05.061_bib7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM198904063201407","article-title":"Beyond cholesterol","volume":"320","author":"Steinberg","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.061_bib8","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1073\/pnas.86.4.1372","article-title":"Low density lipoprotein undergoes oxidative modification in vivo","volume":"86","author":"Palinski","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2009.05.061_bib9","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1073\/pnas.78.10.6499","article-title":"Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins","volume":"78","author":"Henriksen","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2009.05.061_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.ATV.3.2.149","article-title":"Enhanced macrophage degradation of biologically modified low density lipoprotein","volume":"3","author":"Henriksen","year":"1983","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jacc.2009.05.061_bib11","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1172\/JCI115532","article-title":"Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein","volume":"88","author":"Navab","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2009.05.061_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.ATV.21.4.481","article-title":"HDL and the inflammatory response induced by LDL-derived oxidized phospholipids","volume":"21","author":"Navab","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2009.05.061_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nsmb767","article-title":"Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes","volume":"11","author":"Harel","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jacc.2009.05.061_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2009.05.061_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2009.05.061_bib16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions","volume":"101","author":"Aviram","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2009.05.061_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jacc.2009.05.061_bib18","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase","volume":"96","author":"Watson","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2009.05.061_bib19","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.18.10.1617","article-title":"Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase\/paraoxonase activities: selective action of human paraoxonase allozymes Q and R","volume":"18","author":"Aviram","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2009.05.061_bib20","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.CIR.0000070954.00271.13","article-title":"Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study","volume":"107","author":"Mackness","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.061_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1194\/jlr.M400052-JLR200","article-title":"Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia","volume":"46","author":"van Himbergen","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacc.2009.05.061_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2362.2007.01769.x","article-title":"Genetic and environmental determinants of the PON-1 phenotype","volume":"37","author":"Roest","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacc.2009.05.061_bib23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(04)15642-0","article-title":"Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies","volume":"363","author":"Wheeler","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.061_bib24","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/01.CIR.91.10.2528","article-title":"Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels","volume":"91","author":"Jukema","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.061_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199801083380203","article-title":"The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis","volume":"338","author":"Kuivenhoven","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.061_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jech.46.2.136","article-title":"Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts","author":"Herings","year":"1992","journal-title":"J Epidemiol Comm Health"},{"key":"10.1016\/j.jacc.2009.05.061_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1515\/CCLM.1998.096","article-title":"A multilocus genotyping assay for cardiovascular disease","volume":"36","author":"Cheng","year":"1998","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacc.2009.05.061_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.ATV.0000121573.29550.1a","article-title":"In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction","volume":"24","author":"Tregouet","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2009.05.061_bib29","series-title":"Progression and Regression of Atherosclerosis","first-page":"478","article-title":"Future perspectives in atherosclerosis research: an epidemiologic view","author":"Grobbee","year":"1995"},{"key":"10.1016\/j.jacc.2009.05.061_bib30","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/01.CIR.0000065118.99409.5F","article-title":"Coronary collaterals: an important and underexposed aspect of coronary artery disease","volume":"107","author":"Koerselman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.061_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.73.1.1","article-title":"Prevention of coronary heart disease\u2014propaganda, promises, problems, and prospects","volume":"73","author":"Oliver","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.061_bib32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0021-9150(00)00495-0","article-title":"A prospective study of paraoxonase gene Q\/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin","volume":"154","author":"Turban","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2009.05.061_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1086\/345312","article-title":"Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study","volume":"72","author":"Chen","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2009.05.061_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2007.04.004","article-title":"Association of paraoxonase activity and coronary blood flow","volume":"197","author":"Yildiz","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2009.05.061_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2796.2005.01557.x","article-title":"The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia","volume":"258","author":"Himbergen","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacc.2009.05.061_bib36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00008571-200110000-00009","article-title":"Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol","volume":"11","author":"Malin","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jacc.2009.05.061_bib37","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1185\/030079907X226104","article-title":"Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol","volume":"23","author":"Bergheanu","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jacc.2009.05.061_bib38","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1161\/01.ATV.0000096207.01487.36","article-title":"Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2","volume":"23","author":"Deakin","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2009.05.061_bib39","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/01.ATV.20.9.2113","article-title":"Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients","volume":"20","author":"Tomas","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2009.05.061_bib40","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJM199605023341801","article-title":"Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease","volume":"334","author":"Hennekens","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.061_bib41","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM200001203420302","article-title":"Vitamin E supplementation and cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.061_bib42","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/01.ATV.0000027101.40323.3A","article-title":"Vitamin C and E intake is associated with increased paraoxonase activity","volume":"22","author":"Jarvik","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2009.05.061_bib43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bcp.2004.08.027","article-title":"Modulation of paraoxonase (PON1) activity","volume":"69","author":"Costa","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacc.2009.05.061_bib44","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1128\/MCB.24.12.5209-5222.2004","article-title":"Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism","volume":"24","author":"Gouedard","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jacc.2009.05.061_bib45","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1161\/01.ATV.0000146530.24736.ce","article-title":"Induction of the paraoxonase-1 gene expression by resveratrol","volume":"24","author":"Gouedard","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709022499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709022499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:34:08Z","timestamp":1760013248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109709022499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":45,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0735109709022499"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2009.05.061","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.05.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.07.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}